These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23965477)

  • 1. Rituximab-induced serum sickness in overlapping syndrome between sjögren syndrome and systemic lupus erythematosus.
    Ungprasert P; Srivali N; Kittanamongkolchai W; Leeaphorn N; Griger DT
    J Clin Rheumatol; 2013 Sep; 19(6):360. PubMed ID: 23965477
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of serum sickness-like symptoms after rituximab infusion in two patients with severe hypergammaglobulinemia.
    Finger E; Scheinberg M
    J Clin Rheumatol; 2007 Apr; 13(2):94-5. PubMed ID: 17414540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sickness following treatment with rituximab.
    Todd DJ; Helfgott SM
    J Rheumatol; 2007 Feb; 34(2):430-3. PubMed ID: 17295433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment.
    Hellerstedt B; Ahmed A
    Ann Oncol; 2003 Dec; 14(12):1792. PubMed ID: 14630688
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum sickness and severe angioedema following rituximab therapy in RA.
    Kumar A; Khamkar K; Gopal H
    Int J Rheum Dis; 2012 Feb; 15(1):e6-7. PubMed ID: 22324965
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus.
    Kishi J; Nanki T; Watanabe K; Takamura A; Miyasaka N
    Rheumatology (Oxford); 2009 Apr; 48(4):447-8. PubMed ID: 19202159
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab-induced serum sickness.
    Herishanu Y
    Am J Hematol; 2002 Aug; 70(4):329. PubMed ID: 12214584
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum sickness induced by rituximab infusion; report of two cases with hematological malignancies].
    Matsui T; Hidaka M; Kawakita T; Inoue Y; Sakai T; Harada N; Takemoto S; Nagakura S; Tsukamoto A; Kiyokawa T; Kawano F
    Rinsho Ketsueki; 2009 Apr; 50(4):304-8. PubMed ID: 19404025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multifocal leucoencephalopathy in a patient with systemic lupus erythematosus treated with rituximab.
    Harris HE
    Rheumatology (Oxford); 2008 Feb; 47(2):224-5. PubMed ID: 18045807
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab-induced serum sickness.
    Schutgens RE
    Br J Haematol; 2006 Oct; 135(2):147. PubMed ID: 16869826
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum sickness following a first rituximab infusion with no recurrence after the second one.
    Mehsen N; Yvon CM; Richez C; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(5):967. PubMed ID: 19032839
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia.
    Catuogno M; Rezai S; Priori R; Magrini L; Valesini G
    Rheumatology (Oxford); 2005 Mar; 44(3):406. PubMed ID: 15637037
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe serum sickness-like syndrome after omalizumab therapy for asthma.
    Pilette C; Coppens N; Houssiau FA; Rodenstein DO
    J Allergy Clin Immunol; 2007 Oct; 120(4):972-3. PubMed ID: 17716723
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab in lupus and beyond: the state of the art.
    Hughes G
    Lupus; 2009 Jun; 18(7):639-44. PubMed ID: 19433465
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus.
    Kamiya K; Kurasawa K; Arai S; Maezawa R; Hanaoka R; Kumano K; Fukuda T
    Mod Rheumatol; 2010 Feb; 20(1):81-5. PubMed ID: 19784542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab-induced lupus erythematosus.
    Al-Niaimi F
    Eur J Dermatol; 2009; 19(4):380. PubMed ID: 19451046
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al.
    Ramos-Casals M; Díaz-Lagares C; Khamashta MA
    Arthritis Rheum; 2009 Sep; 61(9):1281-2. PubMed ID: 19714598
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab.
    Pérez-García C; Maymo J; Lisbona Pérez MP; Almirall Bernabé M; Carbonell Abelló J
    Rheumatology (Oxford); 2006 Jan; 45(1):114-6. PubMed ID: 16319096
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug-induced systemic lupus erythematosus: reports to The Netherlands Pharmacovigilance Centre Lareb].
    van Rijthoven AW; van Roon JA
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):839; author reply 839. PubMed ID: 17469329
    [No Abstract]   [Full Text] [Related]  

  • 20. Adalimumab-induced lupus erythematosus.
    Martín JM; Ricart JM; Alcácer J; Rausell N; Arana G
    Lupus; 2008 Jul; 17(7):676-8. PubMed ID: 18625641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.